Possible mechanism of liver necrosis caused by aromatic organic compounds.
Treatment of rats with phenobarbital, which stimulates the activity of the drug-metabolizing enzymes in the liver, potentiates hepatic necrosis elicited by bromobenzene and a number of other chemically inert halogenated aromatic hydrocarbons. Radioautographic studies indicate that [(14)C]bromobenzene is covalently bound at the sites of necrosis. From these results, it is inferred that the hepatotoxic effects of the halogenated aromatic hydrocarbons are mediated by chemically active metabolites formed in hepatocytes. In accord with this view, a number of aromatic halogenated hydrocarbons are converted by microsomes in vitro to active intermediates which form covalent complexes with glutathione (GSH).
D000818:Animals; D001345:Autoradiography; D001555:Benzene Derivatives / Q000378:metabolism; D002247:Carbon Isotopes; D056486:Chemical and Drug Induced Liver Injury; D002854:Chromatography, Paper; D004357:Drug Synergism; D005978:Glutathione / Q000378:metabolism; D006846:Hydrocarbons, Halogenated / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008107:Liver Diseases / Q000473:pathology; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D009249:NADP / Q000378:metabolism; D009281:Naphthalenes; D009336:Necrosis; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats
D001555:Benzene Derivatives; D002247:Carbon Isotopes; D006846:Hydrocarbons, Halogenated; D009281:Naphthalenes; D009249:NADP; D005978:Glutathione; D010634:Phenobarbital